Written by Justo Torres.

A federal government shutdown—technically a funding lapse—is a structural consequence of the Antideficiency Act. This federal law prevents agencies from spending or committing funds that have not been formally appropriated by Congress. If the fiscal year ends without new spending bills or a “continuing resolution” in place, agencies must suspend most operations until new funding is legally authorized.

Administrative and Financial Impacts

The disruption to scientific progress extends beyond the laboratory, impacting the administrative “pipeline” and institutional cash flow:

• Proposal Submission and Review: Electronic portals like Grants.gov typically remain open, but the human element of the review process halts. Peer-review panels are canceled and must be rescheduled, creating a backlog that can delay new project starts by several months.
• Delayed Reimbursements: While researchers on existing grants are often encouraged to continue their work, the federal systems that process payments may only operate intermittently. This often forces universities and research institutions to “front” the costs for salaries and supplies using their own reserves. The cost of “floating” grant expenditures and unspecified periods of time could prove a burden on institutional cash reserves.
• Individual Financial Strain: Reimbursements for researcher travel, specialized equipment purchases, and minor out-of-pocket expenses are typically paused. While these funds are eventually restored once the government reopens, the delay can create temporary financial hurdles for individual laboratories and staff.
• Contracts vs. Grants: Unlike grants, which often have obligated funds that allow work to continue, federal contracts are more likely to receive “stop-work” orders. In these cases, expenses incurred during the shutdown may not be reimbursable, leading to potential project terminations.

Ultimately, while the scientific community is resilient, these lapses require significant administrative effort to navigate, shifting focus from discovery to contingency planning.